| Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark T Jess, L Riis, I Vind, KV Winther, S Borg, V Binder, E Langholz, ... Inflammatory bowel diseases 13 (4), 481-489, 2006 | 496 | 2006 |
| The costs of exacerbations in chronic obstructive pulmonary disease (COPD) F Andersson, S Borg, SA Jansson, AC Jonsson, ÅSA ERICSSON, C Prütz, ... Respiratory medicine 96 (9), 700-708, 2002 | 368 | 2002 |
| Costs of COPD in Sweden according to disease severity SA Jansson, F Andersson, S Borg, Å Ericsson, E Jönsson, B Lundbäck Chest 122 (6), 1994-2002, 2002 | 272 | 2002 |
| A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease S Borg, Å Ericsson, J Wedzicha, A Gulsvik, B Lundbäck, GC Donaldson, ... Value in Health 7 (2), 153-167, 2004 | 116 | 2004 |
| Obesity, survival, and hospital costs—findings from a screening project in Sweden S Borg, U Persson, K Ödegaard, G Berglund, JÅ Nilsson, PM Nilsson Value in Health 8 (5), 562-571, 2005 | 108 | 2005 |
| Costs and quality of life in multiple sclerosis patients with spasticity J Svensson, S Borg, P Nilsson Acta neurologica Scandinavica 129 (1), 13-20, 2014 | 80 | 2014 |
| Health-related quality of life and glycaemic control among adults with type 1 and type 2 diabetes–a nationwide cross-sectional study M Svedbo Engström, J Leksell, UB Johansson, S Borg, B Palaszewski, ... Health and quality of life outcomes 17, 1-11, 2019 | 77 | 2019 |
| Drug and treatment costs in Parkinson’s disease patients in Sweden J Lökk, S Borg, J Svensson, U Persson, G Ljunggren Acta Neurologica Scandinavica 125 (2), 142-147, 2012 | 64 | 2012 |
| Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources M Hoogendoorn, TL Feenstra, M Boland, AH Briggs, S Borg, SA Jansson, ... International journal of chronic obstructive pulmonary disease 12, 3183, 2017 | 55 | 2017 |
| The impact of exacerbations on the asthmatic patient's preference scores F Andersson, S Borg, E Ståhl Journal of Asthma 40 (6), 615-623, 2003 | 52 | 2003 |
| Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios M Hoogendoorn, TL Feenstra, Y Asukai, S Borg, RN Hansen, SA Jansson, ... Value in Health 17 (5), 525-536, 2014 | 50 | 2014 |
| The Swedish cost burden of overweight and obesity–evaluated with the PAR approach and a statistical modelling approach K Odegaard, S Borg, U Persson, M Svensson International Journal of Pediatric Obesity 3 (sup1), 51-57, 2008 | 49 | 2008 |
| A disease-specific questionnaire for measuring patient-reported outcomes and experiences in the Swedish National Diabetes Register: Development and evaluation of content … MS Engström, J Leksell, UB Johansson, K Eeg-Olofsson, S Borg, ... Patient education and counseling 101 (1), 139-146, 2018 | 44 | 2018 |
| Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden T Hofmarcher, S Borg Journal of medical economics 18 (7), 492-501, 2015 | 34 | 2015 |
| Budesonide/formoterol in a single inhaler (Symbicort) reduces healthcare costs compared with separate inhalers in the treatment of asthma over 12 months. L Rosenhall, S Borg, F Andersson, K Ericsson International journal of clinical practice 57 (8), 662-667, 2003 | 32 | 2003 |
| Patient-reported outcome and experience measures for diabetes: development of scale models, differences between patient groups and relationships with cardiovascular and … S Borg, K Eeg-Olofsson, B Palaszewski, MS Engström, UG Gerdtham, ... BMJ open 9 (1), e025033, 2019 | 29 | 2019 |
| Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort UG Gerdtham, LF Andersson, Å Ericsson, S Borg, SA Jansson, ... The European Journal of Health Economics 10 (2), 217-226, 2009 | 29 | 2009 |
| Patient-reported outcome measures and risk factors in a quality registry: a basis for more patient-centered diabetes care in Sweden S Borg, B Palaszewski, UG Gerdtham, Ö Fredrik, P Roos, ... International journal of environmental research and public health 11 (12 …, 2014 | 24 | 2014 |
| Cost differences for COPD with and without physician-diagnosis SA Jansson, A Lindberg, Å Ericsson, S Borg, E Rönmark, F Andersson, ... COPD: Journal of Chronic Obstructive Pulmonary Disease 2 (4), 427-434, 2005 | 24 | 2005 |
| Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden S Borg, H Nahi, M Hansson, D Lee, J Elvidge, U Persson Acta Oncologica 55 (5), 554-560, 2016 | 22 | 2016 |
Bo Lundbäckprofessor i lungsjukdomars epidemiologi, Göteborgs universitetAdresse e-mail validée de gu.se
